The efficacy of biodegradable polymer everolimus-eluting stents in patients with cardiac allograft vasculopathy
PCI with BP-DES was associated with a lower TVNLR than PCI with DP-DES. Both DES resulted in similar clinical outcomes; however, a long-term investigation is warranted.
Authors
- Babak Azarbal
- E. Kransdorf (ORCID: https://orcid.org/0000-0002-0507-2412)
- Andriana Nikolova (ORCID: https://orcid.org/0000-0002-2274-5869)
- Jon Kobashigawa (ORCID: https://orcid.org/0000-0001-9308-3172)
- L. Stern (ORCID: https://orcid.org/0000-0003-3024-9563)
- Michelle M Kittleson (ORCID: https://orcid.org/0000-0002-5537-0573)
- D. Chang (ORCID: https://orcid.org/0000-0002-5361-0035)
- Masaki Tsuji
Institutions
- Cedars-Sinai Medical Center (US)
- Cedars-Sinai Smidt Heart Institute (US)
- The University of Tokyo (JP)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100408
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Abbott Laboratories
- Sanofi
- Alnylam Pharmaceuticals
- CSL Behring
- Amarin Corporation
- CareDx
- Fukuda Foundation for Medical Technology
- Japanese Circulation Society
- Sanofi Genzyme